Search Results - "INA, Shinomi"

A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy by Tani, Masaji, M.D, Kawai, Manabu, M.D, Hirono, Seiko, M.D, Ina, Shinomi, M.D, Miyazawa, Motoki, M.D, Shimizu, Atsushi, M.D, Yamaue, Hiroki, M.D

“…Abstract Background A stent often is placed across the pancreaticojejunostomy. However, there is no report compared between internal drainage and external…”
Get full text

How Do We Predict the Clinically Relevant Pancreatic Fistula After Pancreaticoduodenectomy?—An Analysis in 244 Consecutive Patients by Kawai, Manabu, Tani, Masaji, Hirono, Seiko, Ina, Shinomi, Miyazawa, Motoki, Yamaue, Hiroki

“…Background The most important problem in pancreatic fistula is whether one can distinguish clinical pancreatic fistula, grade B + C fistula by the…”
Get full text

A Central Pancreatectomy for Benign or Low-Grade Malignant Neoplasms by Hirono, Seiko, Tani, Masaji, Kawai, Manabu, Ina, Shinomi, Nishioka, Ryohei, Miyazawa, Motoki, Shimizu, Atsushi, Uchiyama, Kazuhisa, Yamaue, Hiroki

“…Inctroduction A central pancreatectomy is a parenchyma-sparing procedure that is performed to reduce long-term endocrine and exocrine insufficiency. Method In…”
Get full text

A pancreaticoduodenectomy is acceptable for periampullary tumors in the elderly, even in patients over 80 years of age by Tani, Masaji, Kawai, Manabu, Hirono, Seiko, Ina, Shinomi, Miyazawa, Motoki, Nishioka, Ryohei, Shimizu, Atsushi, Uchiyama, Kazuhisa, Yamaue, Hiroki

“…Background Although the mortality rates for pancreaticoduodenectomy have been reported to be low for periampullary tumors at high‐volume centers, postoperative…”
Get full text

Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome‐wide expression profiling by Hirono, Seiko, Yamaue, Hiroki, Hoshikawa, Yutaka, Ina, Shinomi, Tani, Masaji, Kawai, Manabu, Ushijima, Masaru, Matsuura, Masaaki, Saiki, Yuriko, Saiura, Akio, Yamamoto, Junji, Miki, Yoshio, Noda, Tetsuo

“…Lymph node metastasis (LNM) is the most important prognostic factor in patients undergoing surgical resection of pancreatic ductal adenocarcinoma (PDAC). In…”
Get full text

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy by Kiyotani, Kazuma, Uno, Satoko, Mushiroda, Taisei, Takahashi, Atsushi, Kubo, Michiaki, Mitsuhata, Naoki, Ina, Shinomi, Kihara, Chikashi, Kimura, Yasutoshi, Yamaue, Hiroki, Hirata, Koichi, Nakamura, Yusuke, Zembutsu, Hitoshi

“…OBJECTIVEGenetic factors are thought to be one of the causes of individual variability in the adverse reactions observed in cancer patients who received…”
Get full text

Indication of Hepatopancreatoduodenectomy for Biliary Tract Cancer by Hirono, Seiko, Tani, Masaji, Kawai, Manabu, Ina, Shinomi, Uchiyama, Kazuhisa, Yamaue, Hiroki

“…Background The indication for a hepatopancreatoduodenectomy (HPD) in patients with advanced biliary tract cancer is still controversial, because this…”
Get full text

CLIP Method (Preoperative CT Image-assessed Ligation of Inferior Pancreaticoduodenal Artery) Reduces Intraoperative Bleeding during Pancreaticoduodenectomy by Kawai, Manabu, Tani, Masaji, Ina, Shinomi, Hirono, Seiko, Nishioka, Ryohei, Miyazawa, Motoki, Uchiyama, Kazuhisa, Shimamoto, Tetsuya, Yamaue, Hiroki

“…Background No previous reports have prospectively discussed an operative approach to reducing intraoperative bleeding during pancreaticoduodenectomy (PD). We…”
Get full text

MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography by Shimamoto, Tetsuya, Tani, Masaji, Kawai, Manabu, Hirono, Seiko, Ina, Shinomi, Miyazawa, Motoki, Shimizu, Atsushi, Uchiyama, Kazuhisa, Yokoyama, Shozo, Tsutsumi, Masahiro, Yamaue, Hiroki

“…Some intraductal papillary mucinous neoplasms (IPMNs) have no proliferation to malignant IPMNs, and benign IPMNs can observe the natural course without a…”
Get full text

Xanthogranulomatous cholecystitis: the use of preoperative CT findings to differentiate it from gallbladder carcinoma by Uchiyama, Kazuhisa, Ozawa, Satoru, Ueno, Masaki, Hayami, Shinya, Hirono, Seiko, Ina, Shinomi, Kawai, Manabu, Tani, Masaji, Yamaue, Hiroki

“…Background and aim A retrospective analysis was performed on 32 patients with histologically confirmed xanthogranulomatous cholecystitis (XGC) and 21 patients…”
Get full text

Complications with Reconstruction Procedures in Pylorus‐preserving Pancreaticoduodenectomy by Tani, Masaji, Kawai, Manabu, Terasawa, Hiroshi, Ueno, Masaki, Hama, Takashi, Hirono, Seiko, Ina, Shinomi, Uchiyama, Kazuhisa, Yamaue, Hiroki

“…This study was conducted retrospectively to examine the efficacy of Traverso reconstruction compared with Billroth I reconstruction after pylorus‐preserving…”
Get full text

Phase 2 Trial of Oral S-1 Combined with Low-dose Cisplatin for Unresectable Advanced Pancreatic Cancer by INA, Shinomi, TANI, Masaji, KAWAI, Manabu, HIRONO, Seiko, MIYAZAWA, Motoki, NISHIOKA, Ryohei, FUJITA, Yoichi, YAMAUE, Hiroki

“…Objectives: A phase 2 trial of S-1 combined with cisplatin was conducted for unresectable pancreatic cancer. Patients and Methods: S-1 was administered for 28…”
Get full text

Prognostic factors for long‐term survival in patients with locally invasive pancreatic cancer by Tani, Masaji, Kawai, Manabu, Terasawa, Hiroshi, Ina, Shinomi, Hirono, Seiko, Shimamoto, Tetsuya, Miyazawa, Motoki, Uchiyama, Kazuhisa, Yamaue, Hiroki

“…Background/Purpose We aimed to investigate predictors of survival in patients with resectable locally invasive pancreatic cancer. Methods The patient cohort…”
Get full text

Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection : Prospective study for 104 consecutive patients by KAWAI, Manabu, TANI, Masaji, TERASAWA, Hiroshi, INA, Shinomi, HIRONO, Seiko, NISHIOKA, Ryohei, MIYAZAWA, Motoki, UCHIYAMA, Kazuhisa, YAMAUE, Hiroki

“…The aim of this study was designed to determine whether the period of drain insertion influences the incidence of postoperative complications. The significance…”
Get full text

Pylorus-preserving pancreaticoduodenectomy versus conventional pancreaticoduodenectomy for pancreatic adenocarcinoma by Tani, Masaji, Kawai, Manabu, Hirono, Seiko, Ina, Shinomi, Miyazawa, Motoki, Fujita, Yoichi, Uchiyama, Kazuhisa, Yamaue, Hiroki

Get full text

Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy : Results of a prospective, randomized, controlled trial by TANI, Masaji, TERASAWA, Hiroshi, KAWAI, Manabu, INA, Shinomi, HIRONO, Seiko, UCHIYAMA, Kazuhisa, YAMAUE, Hiroki

“…To determine if an antecolic or a retrocolic duodenojejunostomy during pylorus-preserving pancreaticoduodenectomy (PpPD) was associated with the least…”
Get full text

Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance by Ina, Shinomi, Hirono, Seiko, Noda, Tetsuo, Yamaue, Hiroki

“…Gemcitabine is the standard chemotherapeutic agent for pancreatic cancer. Nevertheless, the prognosis of pancreatic cancer patients is still poor. Evaluating…”
Get full text

Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma by Tani, Masaji, Kawai, Manabu, Miyazawa, Motoki, Hirono, Seiko, Ina, Shinomi, Nishioka, Ryohei, Fujita, Yoichi, Uchiyama, Kazuhisa, Yamaue, Hiroki

“…Background Prognosis of the patients with pancreatic adenocarcinoma is still poor due to a recurrence, and liver metastasis is a distant metastasis that is…”
Get full text

Pylorus-preserving pancreaticoduodenectomy versus conventional pancreaticoduodenectomy for pancreatic adenocarcinoma by Tani, Masaji, Kawai, Manabu, Hirono, Seiko, Ina, Shinomi, Miyazawa, Motoki, Fujita, Yoichi, Uchiyama, Kazuhisa, Yamaue, Hiroki

“…Purpose A few randomized controlled trials have questioned the justification of pylorus-preserving pancreaticoduodenectomy (PpPD) for pancreatic cancer and…”
Get full text

A collision tumor composed of cancers of the bile duct and ampulla of Vater--immunohistochemical analysis of a rare entity of double cancer by Hirono, Seiko, Tani, Masaji, Terasawa, Hiroshi, Kawai, Manabu, Ina, Shinomi, Uchiyama, Kazuhisa, Nakamura, Yasushi, Kakudo, Kenichi, Yamaue, Hiroki

“…Collision cancer of the bile duct and the papilla of Vater is an extremely rare entity. This is the first report of a case of bile duct collision cancer. A…”
Get more information